Can Lacosamide and Gabapentin Be Combined?
Yes, lacosamide and gabapentin can be safely combined without clinically significant pharmacokinetic interactions, and this combination may provide synergistic anticonvulsant effects for seizure control.
Evidence for Co-Administration
No Pharmacokinetic Interactions
The FDA drug labeling for gabapentin does not list lacosamide as having any interaction 1. Both medications have favorable pharmacokinetic profiles that minimize drug-drug interactions:
- Gabapentin is renally excreted without hepatic metabolism and is not protein-bound 2
- Lacosamide is similarly minimally protein-bound and primarily renally excreted 2
- Neither drug undergoes significant cytochrome P450 metabolism, eliminating the most common pathway for drug interactions 2
Synergistic Anticonvulsant Effects
The combination of lacosamide and gabapentin demonstrates synergistic anticonvulsant activity in preclinical models 3. In the 6-Hz seizure model in mice, combining lacosamide with gabapentin at various dose ratios (1:3,1:1, and 3:1) produced synergistic effects without enhanced adverse motor effects on rotarod testing. Importantly, no pharmacokinetic interactions were detected in brain or blood AED concentrations 3.
Clinical Context
Both drugs are indicated as adjunctive therapy for partial-onset seizures 4. The 2014 emergency medicine guidelines list both medications as having acceptable safety profiles when used in combination with other antiepileptic drugs:
- Gabapentin: Can be rapidly initiated at 900 mg/day without significant adverse effects beyond somnolence, dizziness, ataxia, and fatigue 4
- Lacosamide: Available in both oral and IV formulations with mild to moderate side effects (dizziness, headache, somnolence) 4
Practical Considerations
Overlapping Side Effects
Both medications can cause:
- Dizziness
- Somnolence
- Ataxia
Monitor patients for additive CNS depression, particularly when initiating therapy or increasing doses. Start with lower doses and titrate gradually, especially in older adults or those with renal impairment.
Renal Dosing
Both drugs require dose adjustment in renal insufficiency since they are primarily renally excreted 1. Calculate creatinine clearance and adjust doses accordingly to prevent accumulation and toxicity.
Abrupt Discontinuation
Lacosamide carries a warning about withdrawal seizures with abrupt discontinuation 4. If discontinuing either medication in a patient on combination therapy, taper gradually while maintaining the other agent.
Bottom Line
The combination of lacosamide and gabapentin is pharmacologically sound with no significant drug-drug interactions and potential for synergistic benefit in seizure control 2, 3. The main clinical concern is additive CNS side effects, which can be managed through careful dose titration and patient monitoring. This combination is appropriate for patients with refractory partial-onset seizures requiring polytherapy.